107 related articles for article (PubMed ID: 8143895)
1. Site-directed mutagenesis of hGH at the 54-74 loop selectively modifies its lactogenic receptor-mediated biological activity.
Sakal E; Tchelet A; Uchida E; Shimokawa S; Nishikawa S; Hayakawa T; Krivi GG; Gertler A
Mol Cell Endocrinol; 1993 Nov; 97(1-2):129-34. PubMed ID: 8143895
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity.
Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A
Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914
[TBL] [Abstract][Full Text] [Related]
3. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes.
Vashdi-Elberg D; Staten NR; Sakal E; Krivi GG; Gertler A
Endocrinology; 1995 Mar; 136(3):1258-66. PubMed ID: 7867580
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
[TBL] [Abstract][Full Text] [Related]
5. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells.
Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P
Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties.
Binder L; Gertler A; Elberg G; Guy R; Vogel T
Mol Endocrinol; 1990 Jul; 4(7):1060-8. PubMed ID: 2178223
[TBL] [Abstract][Full Text] [Related]
7. An active site of growth hormone for eliciting the differentiation of preadipose 3T3-F442A cells to adipose cells.
Uchida E; Shimokawa S; Nishida Y; Takasu H; Ikehara M; Uesugi S; Tomita K; Tanaka A; Morikawa M; Hayakawa T
Biochem Biophys Res Commun; 1990 Oct; 172(1):357-63. PubMed ID: 2222479
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG.
Elberg G; Kelly PA; Djiane J; Binder L; Gertler A
J Biol Chem; 1990 Sep; 265(25):14770-6. PubMed ID: 2394695
[TBL] [Abstract][Full Text] [Related]
9. Interaction of recombinant rat placental lactogen-I with extracellular domains of prolactin receptors from three species.
Sakal E; Robertson MC; Chapnik-Cohen N; Tchelet A; Gertler A
Recept Signal Transduct; 1996; 6(1):35-42. PubMed ID: 8933620
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system.
Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Marshall NJ
J Endocrinol; 1994 Mar; 140(3):445-53. PubMed ID: 8182373
[TBL] [Abstract][Full Text] [Related]
11. Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity.
Binder L; Vogel T; Hadary D; Elberg G; Gertler A
Mol Endocrinol; 1989 Jun; 3(6):923-30. PubMed ID: 2739655
[TBL] [Abstract][Full Text] [Related]
12. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
[TBL] [Abstract][Full Text] [Related]
13. Differential in vivo activities of bovine growth hormone analogues.
Kopchick J; Chen XZ; Li Y; Steger RW; Yun JS; Wagner TE; Bartke A
Transgenic Res; 1998 Jan; 7(1):61-71. PubMed ID: 9556914
[TBL] [Abstract][Full Text] [Related]
14. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
[TBL] [Abstract][Full Text] [Related]
15. Selective modification of human growth hormone by site-directed mutagenesis: implications for the diversity of biological actions.
Tchelet A; Gertler A; Sakal E; Djiane J; Vogel T
Horm Res; 1994; 41 Suppl 2():103-12. PubMed ID: 8088697
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of in vitro and in vivo modulation of lactogenic and somatotropic receptors by native human growth hormone and its modified analog prepared by recombinant deoxyribonucleic acid technology.
Ashkenazi A; Vogel T; Barash I; Hadari D; Levanon A; Gorecki M; Gertler A
Endocrinology; 1987 Jul; 121(1):414-9. PubMed ID: 3595523
[TBL] [Abstract][Full Text] [Related]
17. Indication of different lactogen and somatogen binding sites in the human growth hormone molecule as probed with monoclonal antibodies.
Strasburger CJ; Binder L; Elberg G; Cohen-Chapnik N; Kohen F; Gertler A
Mol Cell Endocrinol; 1989 Nov; 67(1):55-62. PubMed ID: 2482210
[TBL] [Abstract][Full Text] [Related]
18. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
[TBL] [Abstract][Full Text] [Related]
19. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells.
Nickel BE; Kardami E; Cattini PA
Endocrinology; 1990 Feb; 126(2):971-6. PubMed ID: 2298178
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
